• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Jill W. Ruppenkamp, MSc

Latest:

Insurer Costs of COVID-19 by Disease Severity and Duration

Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.


Jason Shriver, OT

Latest:

Impact of Functional Recovery on Patients Having Heart Surgery

This article describes the positive impact that actively managing functional recovery has on postacute placement for patients undergoing coronary artery bypass surgery.


Andy Bogart, MS

Latest:

Do Localized Disasters Impact Clinical Measures of Health Care Quality?

This study examines the impact of geographically limited disasters on health care quality performance scores of Medicare Advantage contracts, finding limited impact on performance scores.


Harold A. Pollack, PhD

Latest:

Preventing Tomorrow’s High-Cost Claims: The Rising-Risk Patient Opportunity in Medicaid

For Medicaid care management, focusing on rising-risk patients is more effective than targeting high-cost claimants, whose spending tends to decrease over time due to regression to the mean.


John Cerda, BA

Latest:

Implementing Clinical Informatics Tools for Primary Care–Based Diabetic Retinopathy Screening

The authors describe a primary care–based diabetic retinopathy screening program incorporating telemedicine, strong health information technology engagement, and development of clinical informatics tools.


Lisa M. Nyberg, MD, MPH

Latest:

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.


Joshua Fitch

Latest:

Maternal and Infant RSV Immunization Safe, Effective Regardless of Sequence

Combined or individual use of maternal RSVpreF and infant nirsevimab achieved high antibody levels without safety concerns, supporting current RSV prevention strategies.


Elaine Murphy, BS

Latest:

Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment Duration

A nurse-led personalized care program conducted through a specialty pharmacy prolonged medication persistence among patients with cancer receiving olaparib.


Tory M. Wolff, MBA

Latest:

Frequent Primary Care Visits May Lower Costs for Higher-Risk Commercially Insured Adults

Tory M. Wolff, MBA, discusses his study showing that frequent routine primary care visits may lower costs for higher-risk commercially insured adults.


Robert F. Schuldt, PhD

Latest:

Geographic Variation in Medicare Home Health Expenditures

This study attempts to identify the sources of the significant 2.5-fold variation found in home health expenditures, a possible indicator of inefficiency and waste.


Maureen A. Smith, MD, PhD, MPH

Latest:

Care Transition Management and Patient Outcomes in Hospitalized Medicare Beneficiaries

Hospital care transition activity facilitates uptake of Medicare-reimbursed transitional care management, which is associated with lower spending and better patient outcomes.


Donna Seminara, MD

Latest:

Medical Home Visit Programs During COVID-19 State of Emergency

This report highlights the unique challenges faced by home health programs in addition to discussing how technology and policy changes have helped the elderly homebound during the coronavirus disease 2019 (COVID-19) pandemic.




Paul Jeffrey, PharmD

Latest:

PDTs' Role in Addressing Health Care Disparities and Priorities for Improving PDT Access

In their closing remarks, the panel shares their view on the future of prescription digital therapeutics and the prospects for the widespread adoption and implementation of these therapeutics in health care systems.


Seth Young, BS

Latest:

Consumer-Centric Approach to Enhance Access to Pediatric Specialty Care

The authors’ organization optimized scheduling techniques that improved patient access to pediatric specialists to within 7 calendar days for new patients.


Qinhe Zheng, MS

Latest:

Behavior-Based Diabetes Management: Impact on Care, Hospitalizations, and Costs

The Diabetes Care Rewards program offers a business case for health plans to promote engagement through use of contingent incentives, thus improving health outcomes and lowering costs.


George Runger, PhD

Latest:

Patient Assignment and Quality Performance: A Misaligned System

This article explores the congruence between payer patient assignment and quality performance and the implications for incentive payments in alternative payment models.


Mike Fazio

Latest:

Enhancing Patient Navigation Through Tailored Technology: Mike Fazio

Mike Fazio, director of value-based care at Navista, Cardinal Health, discusses a trending topic at the 2025 Community Oncology Conference: optimizing oncology care with technology.


Sucharita Paul, MD, MPH

Latest:

Pharmacists and Transitions of Care From Emergency Department to Home

Pharmacists’ roles in transitions of care continue to evolve. Evaluation of pharmacist-led interventions as patients transition from emergency department to home is needed.


Karen Jacobson-Sive

Latest:

Characterizing Patients With MDS Who Undergo Allo-HSCT

Patients with myelodysplastic syndromes (MDS) who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) are older and face worse outcomes compared with non-MDS patients, according to posters presented at the 2024 American Society of Hematology meeting.


Luca Menga, MD

Latest:

Looking at Respiratory Health Through a Global Lens at ERS 2025

The European Respiratory Society (ERS) Congress fosters collaboration among global experts, advancing respiratory health and promoting equality in medicine.


Christopher Wilson, MS

Latest:

Growth of Electronic Consultations in the Veterans Health Administration

This study evaluates the growth in electronic consultation use over the first 7 years after its implementation across the entire Veterans Health Administration system.



Logan Lutton

Latest:

A Look at Cancers Where Biomarkers Are Needed

While treatment options are evolving cancer care and extending lifespans, there is still a lack of biomarkers in certain cancers that can help direct treatment or provide early detection.


Lorella Palazzo, PhD

Latest:

A Value Proposition for Pragmatic Clinical Trials

The authors examine the origin, benefits, and challenges of pragmatic clinical trials to assess the ultimate value of this research design.


Elena Diaz, MD

Latest:

Management of Procalcitonin Test Overuse in an Emergency Department Through a Computer Algorithm

Procalcitonin test demand from the emergency department is growing, necessitating the implementation of strategies to address overuse. Successful interventions must be based on information technology.


Michael J. Fisch, MD, MPH

Latest:

Racial and Ethnic Disparities in Prior Authorizations for Patients With Cancer

The prior authorization process for patients with cancer demonstrates fewer days until submission and lower denial rates for Asian patients relative to White patients.


Philip Niles, MD, MBA

Latest:

Unmet Needs in the Treatment of Wet AMD

Nicholas G. Anderson, MD; Philip Niles, MD, MBA; Kevin U. Stephens, Sr., JD, MD; and Jim Kenney, RPh, MBA, provide insight on unmet needs and future directions for the treatment of wet AMD and DME.


Hayley Virgil

Latest:

Belantamab Mafodotin Improves PFS in Relapsed/Refractory Multiple Myeloma

Second-line treatment with belantamab mafodotin plus bortezomib/dexamethasone in patients with relapsed/refractory multiple myeloma is supported by findings from the phase 3 DREAMM-7 study.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.